155 related articles for article (PubMed ID: 35897110)
21. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
King MT; Tait MA; Campbell R; Müller F; Rutherford C; Beckmore C; Chima S; Langbecker D; Shaw J; Mercieca-Bebber R
Qual Life Res; 2022 Oct; 31(10):2901-2916. PubMed ID: 35553325
[TBL] [Abstract][Full Text] [Related]
22. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
[TBL] [Abstract][Full Text] [Related]
23. Participants' awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey.
González-Saldivar G; Rodríguez-Gutiérrez R; Viramontes-Madrid JL; Salcido-Montenegro A; Álvarez-Villalobos NA; González-Nava V; González-González JG
BMC Med Ethics; 2019 Jan; 20(1):2. PubMed ID: 30621692
[TBL] [Abstract][Full Text] [Related]
24. A quality analysis of clinical anaesthesia study protocols from the Chinese clinical trials registry according to the SPIRIT statement.
Yang L; Chen S; Yang D; Li J; Wu T; Zuo Y
Oncotarget; 2018 May; 9(37):24830-24836. PubMed ID: 29872509
[TBL] [Abstract][Full Text] [Related]
25. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review.
Clark T; Berger U; Mansmann U
BMJ; 2013 Mar; 346():f1135. PubMed ID: 23518273
[TBL] [Abstract][Full Text] [Related]
26. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
27. An Evaluation of Reporting Guidelines and Clinical Trial Registry Requirements Among Addiction Medicine Journals.
Cooper CM; Gray H; Barcenas L; Torgerson T; Checketts JX; Vassar M
J Am Osteopath Assoc; 2020 Dec; 120(12):823-830. PubMed ID: 33075122
[TBL] [Abstract][Full Text] [Related]
28. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
[TBL] [Abstract][Full Text] [Related]
29. Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.
Neuman MD; Gaskins LJ; Ziolek T;
Clin Trials; 2018 Feb; 15(1):107-111. PubMed ID: 28982261
[TBL] [Abstract][Full Text] [Related]
30. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
31. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
32. Adherence of non-pharmaceutically sponsored oncology trial protocols to the International Conference on Harmonization (ICH) guidelines in an academic institution outside the ICH jurisdictions and the impact of IRB implementation on this adherence.
Zeeneldin AA
J Egypt Natl Canc Inst; 2013 Jun; 25(2):71-8. PubMed ID: 23719405
[TBL] [Abstract][Full Text] [Related]
33. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
Kumar S; Mohammad H; Vora H; Kar K
J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
[TBL] [Abstract][Full Text] [Related]
34. How to use the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) in orthodontic research.
Novaes IC; Clementino LC; Flores-Mir C; Marques LS; Martins-Júnior PA
Dental Press J Orthod; 2022; 27(3):e2220290. PubMed ID: 35792787
[TBL] [Abstract][Full Text] [Related]
35. Redactions in protocols for drug trials: what industry sponsors concealed.
Marquardsen M; Ogden M; Gøtzsche PC
J R Soc Med; 2018 Apr; 111(4):136-141. PubMed ID: 29370569
[TBL] [Abstract][Full Text] [Related]
36. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
37. Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review.
Villacampa G; Patel D; Zheng H; McAleese J; Rekowski J; Solovyeva O; Yin Z; Yap C
EClinicalMedicine; 2023 Jun; 60():102020. PubMed ID: 37261325
[TBL] [Abstract][Full Text] [Related]
38. Completeness of clinical evidence citation in trial protocols: A cross-sectional analysis.
Sheng J; Feldhake E; Zarin DA; Kimmelman J
Med; 2022 May; 3(5):335-343.e6. PubMed ID: 35584654
[TBL] [Abstract][Full Text] [Related]
39. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
Calvert M; King M; Mercieca-Bebber R; Aiyegbusi O; Kyte D; Slade A; Chan AW; Basch E; Bell J; Bennett A; Bhatnagar V; Blazeby J; Bottomley A; Brown J; Brundage M; Campbell L; Cappelleri JC; Draper H; Dueck AC; Ells C; Frank L; Golub RM; Griebsch I; Haywood K; Hunn A; King-Kallimanis B; Martin L; Mitchell S; Morel T; Nelson L; Norquist J; O'Connor D; Palmer M; Patrick D; Price G; Regnault A; Retzer A; Revicki D; Scott J; Stephens R; Turner G; Valakas A; Velikova G; von Hildebrand M; Walker A; Wenzel L
BMJ Open; 2021 Jun; 11(6):e045105. PubMed ID: 34193486
[TBL] [Abstract][Full Text] [Related]
40. The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors.
Qureshi R; Gough A; Loudon K
Trials; 2022 Apr; 23(1):359. PubMed ID: 35477436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
